surmount-osa trial tirzepatide results for the treatment of obstructive sleep apnea: Rationale, design, and sample baseline characteristics of the SURMOUNT -OSA phase 3 Tirzepatide Eases Obstructive Sleep Apnea
Pay in 4 interest-free payments of $5.30 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Nov 16 - Nov 21




















![Delta Sleep-Inducing Peptide [DSIP] | 62568-57-4](https://www.biosynth.com/storage/BottleImages/PD/S4/BIOSYNTH_PDS-4054.png)









